• OPEN AN ACCOUNT
Indian Indices
Sensex
76,944.28 -12.99
( -0.02%)
Global Indices
Nasdaq
53,227.35 -353.64
(-0.66%)
Dow Jones
7,711.10 -21.66
(-0.28%)
Hang Seng
66,431.13 119.20
(0.18%)
Nikkei 225
10,792.77 -31.49
(-0.29%)
Forex
USD-INR
95.47 -0.01
(-0.01%)
EUR-INR
110.57 -0.67
(-0.60%)
GBP-INR
129.19 -0.55
(-0.42%)
JPY-INR
0.60 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Dipna Pharmachem Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543594
INE0MC401013
23.697614
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
5.05
13.28
EPS(TTM)
Face Value()
Div & Yield %
1
10
0
 

Sobha gains after total sales value climbs 76% YoY in Q1 FY27
Jul 06,2026
Sales area climbed 61.72% to 23,35,486 square feet (sq.ft) in Q1 FY27, compared with 14,44,117 sq.ft in Q1 FY26. The average price stood at Rs 15,655 per sq.ft in Q1 FY27, up 8.75% YoY.

Bangalore recorded its strongest-ever quarterly sales, registering sales value of Rs 2,067 crore, accounting for 56.5% of the company’s total sales. The NCR region recorded total sales value of Rs 1,384 crore, contributed 37.9% of total sales. Kerala region contributed Rs 134 crore (3.7%), while other cities collectively contributed Rs 71 crore, representing 1.9% of total sales value.

Sobha is the real estate brand in the country that offers international-quality homes and commercial and contractual projects delivered on time through its backward integration model.

The company reported a 124.8% surge in consolidated net profit to Rs 91.84 crore on a 60.2% rise in revenue from operations to Rs 1,987.84 crore in Q4 FY26 over Q4 FY25.